Stryker (SYK) stock forecast for 2025. Forecast tables and graphs.

Stryker (SYK) stock forecast for 2025

The forecast has been updated: October 22, 2021 9:37


Stryker stock price online today

Analyst Target Price

287.44

Dividend Date

29.10.2021

Ex Dividend Date

29.09.2021

Last Split Factor

2:1

Last Split Date

17.05.2004

Should you buy or sell Stryker stock stock today? What is the projected target price level for 2025? How much will it cost in 2025? Stryker stock Stock Monthly Prediction for January, February, March, April, May, July, July, August, September, October, November and December 2025.

We predict the dynamics of the stock market value using resonant artificial intelligence systems.

Technical, fundamental analyzes, news background, general geopolitical situation in the world and other factors are taken into account.

Forecasts are adjusted once a day taking into account the price change of the previous day.

To date, analysts have a $287.44 target price for Stryker stock stock.

Today 200 Day Moving Average is the support level (261.97 $).

50 Day Moving Average is the resistance level (269.81 $).




SYK Forecast for 2025

Month Rate Forecast MIN Rate MAX Rate Volati-
lity, %
Jan 278.31 270.63 289.00 6.36 %
Feb 270.79 264.95 275.51 3.83 %
Mar 265.43 253.17 276.10 8.31 %
Apr 266.39 255.68 276.62 7.57 %
May 273.10 263.76 281.95 6.45 %
Jun 281.95 273.32 287.19 4.83 %
Jul 291.93 284.40 297.71 4.47 %
Aug 304.37 296.70 309.12 4.02 %
Sep 311.67 307.37 324.20 5.19 %
Oct 326.63 322.12 340.94 5.52 %
Nov 330.55 325.00 340.47 4.54 %
Dec 342.05 336.31 347.80 3.30 %

The forecasts table above shows the forecast values of the company's stock price for each month. The Rate Forecast column displays the Optimal Average Forecast Price. The MIN Rate column displays a pessimistic forecast for this month. “MAX Rate” is an optimistic forecast. The % Volatility column represents the approximate monthly volatility of Stryker stock.


Stryker overview

Stryker Address

2825 AIRVIEW BLVD, KALAMAZOO, MI, US

Market Capitalization

102 140 300 000 $

EBITDA

4 624 000 000

PE Ratio

43.93

PEG Ratio

1.915

Dividend Per Share

2.465

Dividend Yield

0.009

EPS

5.46

Quarterly Earnings Growth YOY

-0.392

Quarterly Revenue Growth YOY

0.554

Trailing PE

50.66

Forward PE

25.51

EV To Revenue

6.82

EV To EBITDA

28.85

52 Week High

280.5

52 Week Low

194.14

50 Day Moving Average

269.81

200 Day Moving Average

261.97

Shares Outstanding

377096000

Shares Float

334281000

Shares Short Prior Month

3412100

Short Ratio

4.04

Percent Insiders

7.32

Percent Institutions

75.11

Stryker stock forecast for this year


Stryker stock forecast for Jan 2025.
Estimated Average Forecasted Stryker Price: 278.31. Positive monthly dynamics of the instrument is expected with 6.356% volatility is expected.

Pessimistic forecast: 270.63

Optimistic: 289.00


Stryker stock forecast for Feb 2025.
Estimated Average Forecasted Stryker Price: 270.79. Negative monthly dynamics of the instrument is expected with 3.833% volatility is expected.

Pessimistic forecast: 264.95

Optimistic: 275.51


Stryker stock forecast for Mar 2025.
Estimated Average Forecasted Stryker Price: 265.43. Negative monthly dynamics of the instrument is expected with 8.306% volatility is expected.

Pessimistic forecast: 253.17

Optimistic: 276.10


Stryker stock forecast for Apr 2025.
Estimated Average Forecasted Stryker Price: 266.39. Positive monthly dynamics of the instrument is expected with 7.569% volatility is expected.

Pessimistic forecast: 255.68

Optimistic: 276.62


Stryker stock forecast for May 2025.
Estimated Average Forecasted Stryker Price: 273.10. Positive monthly dynamics of the instrument is expected with 6.451% volatility is expected.

Pessimistic forecast: 263.76

Optimistic: 281.95


Stryker stock forecast for Jun 2025.
Estimated Average Forecasted Stryker Price: 281.95. Positive monthly dynamics of the instrument is expected with 4.830% volatility is expected.

Pessimistic forecast: 273.32

Optimistic: 287.19


Stryker stock forecast for Jul 2025.
Estimated Average Forecasted Stryker Price: 291.93. Positive monthly dynamics of the instrument is expected with 4.471% volatility is expected.

Pessimistic forecast: 284.40

Optimistic: 297.71


Stryker stock forecast for Aug 2025.
Estimated Average Forecasted Stryker Price: 304.37. Positive monthly dynamics of the instrument is expected with 4.017% volatility is expected.

Pessimistic forecast: 296.70

Optimistic: 309.12


Stryker stock forecast for Sep 2025.
Estimated Average Forecasted Stryker Price: 311.67. Positive monthly dynamics of the instrument is expected with 5.192% volatility is expected.

Pessimistic forecast: 307.37

Optimistic: 324.20


Stryker stock forecast for Oct 2025.
Estimated Average Forecasted Stryker Price: 326.63. Positive monthly dynamics of the instrument is expected with 5.518% volatility is expected.

Pessimistic forecast: 322.12

Optimistic: 340.94


Stryker stock forecast for Nov 2025.
Estimated Average Forecasted Stryker Price: 330.55. Positive monthly dynamics of the instrument is expected with 4.544% volatility is expected.

Pessimistic forecast: 325.00

Optimistic: 340.47


Stryker stock forecast for Dec 2025.
Estimated Average Forecasted Stryker Price: 342.05. Positive monthly dynamics of the instrument is expected with 3.304% volatility is expected.

Pessimistic forecast: 336.31

Optimistic: 347.80



Other Healthcare sector assets

Name Symbol Last Close Price Change
Abbott Laboratories
ABT 127.71 (27.10.2021) -0.33 %
AbbVie Inc.
ABBV 108.4 (27.10.2021) -1.00 %
Aeterna Zentaris Inc.
AEZS 0.5889 (27.10.2021) -4.06 %
Allakos Inc.
ALLK 106.71 (27.10.2021) -4.63 %
Allogene Therapeutics, Inc.
ALLO 15.94 (27.10.2021) -0.50 %
Amgen Inc.
AMGN 206.58 (27.10.2021) -1.01 %
Aphria Inc.
APHA 15.38 (07.05.2021) 0.00 %
Atara Biotherapeutics, Inc.
ATRA 14.98 (27.10.2021) -1.45 %
Aurora Cannabis Inc.
ACB 6.84 (27.10.2021) -2.70 %
Becton Dickinson and Company
BDX 245 (27.10.2021) -0.55 %
Biogen Inc.
BIIB 259.95 (27.10.2021) -4.12 %
Biohaven Pharmaceutical Holding Company Ltd.
BHVN 137.1 (27.10.2021) -3.05 %
BioNTech SE
BNTX 278.77 (27.10.2021) -4.66 %
bluebird bio, Inc.
BLUE 22.06 (27.10.2021) 5.30 %
Boston Scientific Corp.
BSX 43.73 (27.10.2021) -1.33 %
Bristol-Myers Squibb Company
BMY 56.49 (27.10.2021) -3.00 %
Canopy Growth Corp.
CGC 12.78 (27.10.2021) -2.96 %
Castle Biosciences, Inc.
CSTL 60.74 (27.10.2021) -1.41 %
CLOVER HEALTH INVESTMENTS, CORP
CLOV 7.91 (15.10.2021) -2.59 %
Eli Lilly and Company
LLY 250.17 (27.10.2021) 0.70 %
Emergent BioSolutions Inc.
EBS 48.23 (27.10.2021) -4.27 %
Exelixis, Inc.
EXEL 21.3 (27.10.2021) -1.66 %
G1 Therapeutics, Inc.
GTHX 13.39 (27.10.2021) -2.41 %
Gilead Sciences, Inc.
GILD 66.77 (27.10.2021) -1.42 %
GlaxoSmithKline plc
GSK 40.42 (27.10.2021) 0.60 %
GoodRx Holdings, Inc.
GDRX 42.42 (27.10.2021) -4.35 %
GW Pharmaceuticals plc.
GWPH 218.96 (05.05.2021) 0.00 %
Incyte Corp.
INCY 64.97 (27.10.2021) -2.37 %
Inovio Pharmaceuticals, Inc.
INO 6.79 (27.10.2021) -0.73 %
Johnson & Johnson
JNJ 163.74 (27.10.2021) -1.21 %
Medtronic plc.
MDT 122.5 (27.10.2021) -1.25 %
Merck & Co., Inc.
MRK 81.54 (27.10.2021) -0.86 %
Moderna, Inc.
MRNA 340.88 (27.10.2021) -1.41 %
Novartis AG
NVS 82.73 (27.10.2021) -2.49 %
Novavax, Inc.
NVAX 141.55 (27.10.2021) 4.86 %
ObsEva SA
OBSV 2.58 (27.10.2021) -3.01 %
OrganiGram Holdings Inc.
OGI 2.24 (27.10.2021) -1.32 %
Pfizer Inc.
PFE 42.97 (27.10.2021) -1.35 %
Regeneron Pharmaceuticals, Inc.
REGN 589.6 (27.10.2021) -0.43 %
Sanofi
SNY 49.57 (27.10.2021) -0.78 %
Schrodinger, Inc.
SDGR 53.73 (27.10.2021) -1.90 %
Senseonics Holdings, Inc.
SENS 3.33 (27.10.2021) -2.63 %
Sorrento Therapeutics, Inc.
SRNE 6.69 (27.10.2021) -0.59 %
Stryker Corp.
SYK 268.5 (27.10.2021) -1.71 %
Sundial Growers Inc.
SNDL 0.6525 (27.10.2021) -1.85 %
Teva Pharmaceutical Industries Lim. (TEVA)
TEVA 8.93 (27.10.2021) -4.90 %
Thermo Fisher Scientific Inc.
TMO 612.29 (27.10.2021) 0.65 %
Tilray, Inc.
TLRY 10.3 (27.10.2021) -3.83 %
UnitedHealth Group, Inc.
UNH 453.48 (27.10.2021) -0.26 %
Veeva Systems Inc.
VEEV 313.46 (27.10.2021) -2.95 %
Zomedica Corp.
ZOM 0.5 (27.10.2021) -2.84 %
Zynerba Pharmaceuticals, Inc.
ZYNE 3.71 (27.10.2021) -1.33 %

Warning: include(include/reklama_bottom.php): failed to open stream: No such file or directory in /home/virtwww/w_leoprophet-com_a7e4ac46/http/wp-content/themes/generatepress/forecast_stock_post_year.php on line 808 Warning: include(): Failed opening 'include/reklama_bottom.php' for inclusion (include_path='.:') in /home/virtwww/w_leoprophet-com_a7e4ac46/http/wp-content/themes/generatepress/forecast_stock_post_year.php on line 808

Denial of responsibility:

The portal leoprophet.com is not responsible for the loss of your money as a result of your use of the information contained on the site, including data, quotes, charts and forecasts. Operations in the stock, foreign exchange and commodity markets involve a high level of risk, and you are solely responsible for your operations. Only speculate with money that you can afford to lose. All prices and forecasts for stocks, indices, futures are indicative and should not be trade dependent. The portal is not responsible for any losses that you may incur as a result of using this data.